Immunology

Rheumatoid Arthritis Immunization on the Horizon

Published in Vaccine Weekly, June 24th, 1996

Important clinical trials for people with rheumatoid arthritis (RA) have begun in Toronto, Ontario, Canada.

Ultraviolet light research at the Wellesley Central Hospital and Toronto Hospital, Western Division, have been chosen to help determine whether RA remission may be triggered by this novel therapy.

Dr. Edward Keystone, Arthritis Society, is confident about the prospects for success of his trials of extracorporeal photochemotherapy, considering a similar concept is already used effectively to aid people with psoriasis. Keystone's optimism is also fueled by the success rate of an earlier, uncontrolled study of photochemotherapy with a small...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry